Last reviewed · How we verify

Pharmacokinetic Evaluation of Serum Testosterone Concentrations After Administration of Clomiphene Citrate

NCT05096169 Phase 2 WITHDRAWN

This is a randomized, open-label trial examining two doses of clomiphene citrate in men with low serum testosterone concentrations (total testosterone (TT) \< 300 ng/dl).

Details

Lead sponsorWeill Medical College of Cornell University
PhasePhase 2
StatusWITHDRAWN
Start date2022-05-01
Completion2025-01

Conditions

Interventions

Primary outcomes

Countries

United States